Dennis J. O'Connell, D.O., InSight Retina Consultants joins with Retasure to prevent vision loss

Share Article

Dennis J. O'Connell, D.O. has partnered to read digital retinal images for Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. Dr. O'Connell is the owner of InSight Retina Consultants in Englewood, Colorado, and has been practicing as a retina specialist in Colorado since 1995.

but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication.

Dennis J. O'Connell, D.O. has partnered to read digital retinal images for Retasure™ by Digital Healthcare, a Wake Forest, NC company specializing in retinal health assessment for diabetics. Dr. O'Connell is the owner of InSight Retina Consultants in Englewood, Colorado, and has been practicing as a retina specialist in Colorado since 1995.

The Retasure™ solution developed by Digital Healthcare provides a simple, affordable, and non-invasive solution that allows physicians to capture their patients' retinal images during a three to five minute procedure. Certified readers, like Dr. O'Connell, use the ophthalmic specific review tools in Retasure™ to assess the images and consult with the primary care physician.

"Diabetic retinopathy is the leading cause of blindness in Americans under the age of 55. Treatments which are currently available are best able to minimize the risk of vision loss when implemented early in the course of retinopathy. Early detection is therefore the cornerstone for decreasing the risk of vision loss from this potentially devastating disease. And, this is where Retasure can make a difference," states Dr. O'Connell.

Scott Sanner, Vice President of North American Operations for Digital Healthcare, agrees. "The National Eye Institute states that diabetic retinopathy is the leading cause of blindness among working age adults in America," he says, "but fewer than half of all diabetic patients are assessed annually for retinopathy, despite the high frequency of this complication."

Digital Healthcare's Retasure solution offers several advantages for primary care and endocrinologist physicians and their patients: It can be operated by non-clinicians; it is non-invasive and requires no dilation. This FDA-approved technology is used by a broad range of doctors and facilities throughout the United States and the United Kingdom, including leading hospitals and research centers, primary care groups, private ophthalmology and optometry groups, family practice residency centers, and internal, multi-specialty and endocrinology groups. More than a million patients around the world have received a retinal health assessment using Digital Healthcare software.

For additional information, please visit http://www.retasure.com

CONTACT: Scott Sanner (866) 539-4213

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website